ANG Stock View

ANG Lifesciences India Ltd
stock-view-header

icon 0.33 | 0.46
Market Cap ₹( Cr.)
947.77
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
28-May-2023
 

The average score for ANG Lifesciences India Ltd stands at 5 against 6, three months back.

ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. The Company’s product portfolio includes antibiotics, antiulcerant, neutraceuticals, anticoagulants, glucocorticoids, anti-inflammatory, antifungal, antihistamines, antimalarial, and anesthetic. Its dosage forms manufactured by Company includes tablets, capsules, oral liquids, liquid injection, prefilled syringe (PFS), dry powder injection and external preparations. The Company’s manufacturing unit is situated at Village Kishan pura, Post office Manpura Baddi Nalagarh Road, Tehsil Nalagarh, District Solan, Himachal Pradesh. The Company manufactures its products in compliance with good manufacturing practices (GMP) requirements.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
80.73
100 DMA(₹)
89.59
200 DMA(₹)
116.56
52 Weeks Range
65.21     211.12